NCT06480526View on ClinicalTrials.gov

Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

RecruitingOBSERVATIONAL

Enrollment

45

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions

High-risk Neuroblastoma

Trial Locations (1)

38105

RECRUITING

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

lead

St. Jude Children's Research Hospital

OTHER